ConductScience.org, home

Paper37094

beta-Adrenoceptor blocking effects and pharmacokinetics of pindolol. A study in hypertensive Africans.

Salako LA and 3 others. Eur J Clin Pharmacol, 1979. Cited by 7 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. beta-Adrenoceptor blocking effects and pharmacokinetics of pindolol. A study in hypertensive Africans. Papers, record 37094. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37094

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
beta-Adrenoceptor blocking effects and pharmacokinetics of pindolol. A study in hypertensive Africans.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.44
iCite
Revised in PubMed
2019-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Salako LAL A
2Falase AOA O
3Ragon AA
4Adio RAR A

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AntagonistsMajor topic
HypertensionMajor topic
PindololMajor topic
Adult
Blood Pressure
Double-Blind Method
Female
Half-Life
Humans
Kinetics
Male
Middle Aged
Physical Exertion
Placebos
Time Factors

Source PubMed

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,122,674The effect of pindolol on exercise-induced cardiac acceleration in relation to plasma levels in man.Clin Pharmacol Ther1975https://conductscience.org/library/papers/1122674PubMed
24,390,683A method for the fluorimetric determination of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB46), a beta-blocking agent, in plasma and urine.Experientia1969https://conductscience.org/library/papers/4390683PubMed
34,870,102Effect of propranolol on elevated arterial blood pressure.Circulation1968https://conductscience.org/library/papers/4870102PubMed
44,871,610Ineffectiveness of propranolol in hypertensive Jamaicans.Br Med J1968https://conductscience.org/library/papers/4871610PubMed
523,136Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise.Br J Clin Pharmacol1978https://conductscience.org/library/papers/23136PubMed
64,398,792Defective cardiac parasympathetic control in patients with heart disease.N Engl J Med1971https://conductscience.org/library/papers/4398792PubMed
74,634,167Prolonged action of pindolol.Br Med J1973https://conductscience.org/library/papers/4634167PubMed
84,853,602Pharmacokinetics of pindolol in man.Eur J Clin Pharmacol1974https://conductscience.org/library/papers/4853602PubMed
9893,736Pharmacokinetics and hepatic extraction ratio of pindolol in hypertensive patients with normal and impaired renal function.J Clin Pharmacol1977https://conductscience.org/library/papers/893736PubMed
1013,958Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.Clin Pharmacokinet1976https://conductscience.org/library/papers/13958PubMed
115,914,852Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise.Circ Res1966https://conductscience.org/library/papers/5914852PubMed
1226,370The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.Br J Clin Pharmacol1978https://conductscience.org/library/papers/26370PubMed
13639,828Single and multiple dose pharmacokinetics of pindolol.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/639828PubMed

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
26,807,087FIRST REPORTS OF CLINICAL PHARMACOKINETICS IN NIGERIA.Ann Ib Postgrad Med2015https://conductscience.org/library/papers/26807087PubMed
23,721,258Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review.BMC Med2013https://conductscience.org/library/papers/23721258PubMed
1,980,202The efficacy of beta-adrenoceptor and calcium-entry blockers in hypertensive blacks.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/1980202PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37094

GET https://conductscience.org/api/papers/v1/37094/authors